Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof

Details for Australian Patent Application No. 2009218069 (hide)

Owner FUSO Pharmaceutical Industries, Ltd. National University Corporation Hokkaido University

Inventors Suzuki, Yusuke; Tahara, Hiroshi; Yamamoto, Keiichi; Suzuki, Yasuhiko

Agent Davies Collison Cave

Pub. Number AU-A-2009218069

PCT Pub. Number WO2009/107775

Priority 2008-046782 27.02.08 JP

Filing date 27 February 2009

Wipo publication date 3 September 2009

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/107775 Priority application(s): WO2009/107775

4 November 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 18 Oct 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009218085-Absorptive article

2009218060-Pharmaceutical composition for transnasal administration